Living Donor Versus Deceased Donor Liver Transplantation for HCC.

J Gastrointest Cancer

Department of Surgery and Liver Transplantation Institute, İnönü University Faculty of Medicine, Elazığ yolu 10.km, 44280, Malatya, Turkey.

Published: December 2020

AI Article Synopsis

Article Abstract

Introduction: Liver transplantation is the definitive treatment modality of the patients having an end-stage liver disease with hepatocellular carcinoma.

Discussion: The number of living donor liver transplantations has been increased because of the deceased donor organ shortage, especially in Asian countries.

Conclusion: Reports of different clinics about the postoperative course and tumor recurrence rates comparing living donor versus deceased donor liver transplantations, besides patient selection criteria, are reviewed along with our clinic's experiences.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12029-020-00481-1DOI Listing

Publication Analysis

Top Keywords

living donor
12
deceased donor
12
donor liver
12
donor versus
8
versus deceased
8
liver transplantation
8
liver transplantations
8
donor
5
liver
5
transplantation hcc
4

Similar Publications

Patients in need of a kidney transplant have the option of receiving a kidney from a living donor or a deceased donor. Patients in the United States who do not have an available living donor typically wait on the deceased donor waiting list for an average of three to five years, although some patients may wait longer. The waiting list is very complex and intended to allocate kidneys in a fair and equitable manner.

View Article and Find Full Text PDF

DNA is subject to continual damage, leaving each cell with thousands of individual DNA lesions at any given moment. The efficiency of DNA repair means that most known classes of lesion have a half-life of minutes to hours, but the extent to which DNA damage can persist for longer durations remains unknown. Here, using high-resolution phylogenetic trees from 89 donors, we identified mutations arising from 818 DNA lesions that persisted across multiple cell cycles in normal human stem cells from blood, liver and bronchial epithelium.

View Article and Find Full Text PDF

Although living donor liver transplantation has evolved, small-for-size syndrome remains a feared complication. Achieving optimal outflow for the graft with limited donor risk is possible with an experienced team and different techniques. Here we describe the technical aspects of living donor liver transplantation using a right lobe graft, including the different types of grafts, venous reconstructions and the importance of preoperative workup.

View Article and Find Full Text PDF

Introduction: Approximately 50% of patients with C3 glomerulopathy (C3G) and primary immune complex-mediated membranoproliferative glomerulonephritis (IC-MPGN) reach kidney failure 10 years after diagnosis. Because these patients are generally young, the majority will be listed for kidney transplantation (KTx). However, reported outcomes in patients transplanted for C3G and IC-MPGN are heterogeneous and conflicting, because they are mainly based on retrospective monocentric studies.

View Article and Find Full Text PDF

Risk Factors and Treatments of Lymphoceles in Living Renal Transplants: A Single-Center Experience.

Exp Clin Transplant

December 2024

>From the Department of Nephrology, Toho University Faculty of Medicine, Tokyo, Japan; and the Department of Urology, Ryukyu University, Okinawa, Japan.

Objectives: This study aimed to determine interventions and identify risk factors for lymphocele formation following kidney transplant.

Materials And Methods: We conducted a retrospective review of 296 adult kidney transplants from 2010 to 2022 to investigate postoperative lymphocele formation. We divided patients into lymphocele cases and nonlymphocele cases.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!